However, melanoma cells reduce the expression of major NK receptors associated with immune function, including NKp30, NKp44, and NKG2D, which leads to the impairment of natural killer cell-mediated cytolytic activity against cancer cells. The gene discussed is KLRK1; the disease is cancer.